ES2125331T3 - Agente terapeutico obtenido a partir de micobacterium vaccae y su utilizacion para luchar contra la infeccion vih con sida. - Google Patents

Agente terapeutico obtenido a partir de micobacterium vaccae y su utilizacion para luchar contra la infeccion vih con sida.

Info

Publication number
ES2125331T3
ES2125331T3 ES93905520T ES93905520T ES2125331T3 ES 2125331 T3 ES2125331 T3 ES 2125331T3 ES 93905520 T ES93905520 T ES 93905520T ES 93905520 T ES93905520 T ES 93905520T ES 2125331 T3 ES2125331 T3 ES 2125331T3
Authority
ES
Spain
Prior art keywords
aids
vaccae
hiv infection
micobacterium
therapeutic agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93905520T
Other languages
English (en)
Inventor
John Lawson Stanford
Graham Arthur William Rook
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University College London
Original Assignee
University College London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University College London filed Critical University College London
Application granted granted Critical
Publication of ES2125331T3 publication Critical patent/ES2125331T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

EL INVENTO SE REFIERE AL EMPLEO DE MATERIAL ANTIGENICO Y/O INMUNOREGULATORIO DERIVADO DE MYCOBACTERIUM VACCAE PARA TRATAMIENTO DE INFECCION DE HIV CON O SIN AIDS Y CON O SIN TUBERCULOSIS ASOCIADA.
ES93905520T 1992-09-14 1993-03-05 Agente terapeutico obtenido a partir de micobacterium vaccae y su utilizacion para luchar contra la infeccion vih con sida. Expired - Lifetime ES2125331T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929219425A GB9219425D0 (en) 1992-09-14 1992-09-14 Therapeutic agent and its use

Publications (1)

Publication Number Publication Date
ES2125331T3 true ES2125331T3 (es) 1999-03-01

Family

ID=10721884

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93905520T Expired - Lifetime ES2125331T3 (es) 1992-09-14 1993-03-05 Agente terapeutico obtenido a partir de micobacterium vaccae y su utilizacion para luchar contra la infeccion vih con sida.

Country Status (18)

Country Link
EP (1) EP0661998B1 (es)
JP (1) JPH06100457A (es)
KR (1) KR100272743B1 (es)
CN (1) CN1060937C (es)
AP (1) AP510A (es)
AT (1) ATE173633T1 (es)
AU (1) AU683835B2 (es)
BR (1) BR9303762A (es)
CA (1) CA2105646A1 (es)
DE (1) DE69322280T2 (es)
DK (1) DK0661998T3 (es)
ES (1) ES2125331T3 (es)
GB (1) GB9219425D0 (es)
HK (1) HK1011289A1 (es)
RU (1) RU2106878C1 (es)
SG (1) SG72610A1 (es)
WO (1) WO1994006466A1 (es)
ZA (1) ZA935575B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5985287A (en) * 1996-08-29 1999-11-16 Genesis Research And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6284255B1 (en) * 1996-08-29 2001-09-04 Genesis Research & Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6406704B1 (en) 1996-08-29 2002-06-18 Genesis Research And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6878377B2 (en) 1996-12-18 2005-04-12 Stanford Rook Limited Mycobacterium vaccae for down-regulation of the Th2 activity of the immune system
ATE307600T1 (de) * 1996-12-18 2005-11-15 Stanford Rook Ltd Verwendung von mycobacterium vaccae zur therapie des chronischen müdigkeitssyndrom
US5968524A (en) * 1997-12-23 1999-10-19 Genesis Research & Development Corp. Methods and compounds for the treatment of immunologically-mediated psoriasis
US6328978B1 (en) 1997-12-23 2001-12-11 Genesis Research & Development Corp. Ltd. Methods for the treatment of immunologically-mediated skin disorders
GB9903539D0 (en) 1999-02-16 1999-04-07 Stanford Rook Ltd Therapy using M.Vaccae
US6350457B1 (en) 1999-06-02 2002-02-26 Genesis Research & Development Corporation Limited Methods and compounds for the treatment of immunologically-mediated diseases using mycobacterium vaccae
UA77666C2 (en) * 2001-01-17 2007-01-15 Kabulesh Mafatlal Khamar Use of mycobacterium w or its components in preparations for treating hiv infection
WO2002056898A2 (en) * 2001-01-17 2002-07-25 Mafatlal Khamar Bakulesh Immunomodulator for the management of human immunodeficiency virus (hiv) disease/infection
GB2400560A (en) * 2002-01-29 2004-10-20 Rajiv Indravadan Modi Method of providing prophylaxis for tuberculosis in hiv positive individuals
WO2003063896A1 (en) * 2002-01-29 2003-08-07 Modi, Rajiv, Indravadan Process of preparing a pharmaceutical composition for immunity against tuberculosis in hiv positive individuals
AU2003209534A1 (en) * 2002-03-08 2003-09-22 Bakulesh Mafatlal Khamar The method of treating tuberculosis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3728367C1 (de) * 1987-08-25 1988-09-01 Burkhard Steglich Mittel zur Immunisierung des menschlichen Koerpers bei HIV-Infektionen
GB8917256D0 (en) * 1989-07-28 1989-09-13 Univ London Biological preparation and its use

Also Published As

Publication number Publication date
AU3642093A (en) 1994-04-12
DK0661998T3 (da) 1999-08-09
DE69322280D1 (de) 1999-01-07
AP510A (en) 1996-07-23
EP0661998A1 (en) 1995-07-12
GB9219425D0 (en) 1992-10-28
CN1089478A (zh) 1994-07-20
KR100272743B1 (ko) 2000-11-15
DE69322280T2 (de) 1999-04-22
SG72610A1 (en) 2001-07-24
CA2105646A1 (en) 1994-03-15
AU683835B2 (en) 1997-11-27
ZA935575B (en) 1994-03-01
RU2106878C1 (ru) 1998-03-20
JPH06100457A (ja) 1994-04-12
HK1011289A1 (en) 1999-07-09
EP0661998B1 (en) 1998-11-25
CN1060937C (zh) 2001-01-24
KR950703360A (ko) 1995-09-20
ATE173633T1 (de) 1998-12-15
AP9300555A0 (en) 1993-10-31
BR9303762A (pt) 1994-03-22
WO1994006466A1 (en) 1994-03-31

Similar Documents

Publication Publication Date Title
ES2125331T3 (es) Agente terapeutico obtenido a partir de micobacterium vaccae y su utilizacion para luchar contra la infeccion vih con sida.
GR3025502T3 (en) Drugs, their manufacture, and their use as painkillers and/or to treat inflammations in humans and animals.
BR0107972A (pt) Uso de uma proteìna ou polinucleotìdeo tat do hiv, nef do hiv, ou tat do hiv ligado(a) a uma proteìna ou polinucleotìdeo nef do hiv (nef-tat), e de uma proteìna ou polinucleotìdeo gp120 do hiv, método para imunizar um ser humano contra o hiv, e, composição de vacina para o uso humano
TR27984A (tr) Silikon asili termoplastik elastomerik kopolimerler ve bunlari iceren sac ve cilt bakimi bilesimleri.
ES2099056T3 (es) Cepas de lactobacillus de origen humano, sus composiciones y usos de las mismas.
ATE73347T1 (de) Antivirales immunotherapeutisches mittel und dessen herstellung.
EP0400076A4 (en) A synthetic antigen evoking anti-hiv response
RU93004600A (ru) Применение mycobacterium vaccae, способ лечения, продукт m vaccae, иммунотерапевтический агент
ATE49115T1 (de) Haarbehandlungsmittel.
ES2088431T3 (es) Preparacion biologica y su utilizacion.
EP0222302A3 (en) Strain of aureobasidium pullulans, preparation process and use
JPS5218813A (en) Plasters for the relief of cutaneous diseases
ES2091186T3 (es) Procedimiento para obtener antigenos protectores contra infecciones y procesos toxicos de bordetella.
BG102404A (en) The application of flupirtin for the prevention and treatment of diseases related to impairement of the haematopoeic cellular system
ES2104223T3 (es) 2-((2-(n-isobutil-n-metil)amino)-bencilsulfinil)bencimidazol como agente antimicrobiano contra helicobacter pylori.
DE68918562D1 (de) Menschliche myeloperoxidase und therapeutische verwendung.
DE59107111D1 (de) 3,5-Diiod-L-Thyronin zur TSH-Suppression und Behandlung von Struma
ES2042818T3 (es) Agente terapeutico para la trombocitopenia.
DE69010523D1 (de) Kit oder Zusammensetzung zur Vorbeugung oder Behandlung von HIV-1 Infektionen.
AU6877587A (en) Expellants of phytopathogenic microbes
ES2165042T3 (es) Vacuna que contiene el virus de la artritis-encefalitis de cabra y utilizacion para inmunoproteccion contra la infeccion por hiv-1.
ES2051621A1 (es) Procedimiento de obtencion de vacuna frente a estafilococos.
WO1988008707A3 (en) Rubradirin derivatives for treatment of hiv infection
CO4180391A1 (es) Vacuna de alta potencia
KR830000907A (ko) 신규 창상 치료제

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 661998

Country of ref document: ES